Changes in subsets of immunocytes in endometrial hyperplasia
- PMID: 32583503
- DOI: 10.1111/aji.13295
Changes in subsets of immunocytes in endometrial hyperplasia
Abstract
Problem: Endometrial hyperplasia (EH) is characterized by an endometrial gland-to-stroma ratio >1 and is one of the most common gynecological diseases in the world. The role of immunocyte subsets in the development of EH remains unknown.
Methods: Patients who underwent dilatation and curettage due to abnormal uterine bleeding were recruited in the present study. Alterations in the numbers of different types of immune cell subsets in the endometrium of patients were analyzed by flow cytometry.
Results: The present study included 48 patients who were divided into three groups, based on the pathological results: (a) proliferative period (PP, n = 12); (b) simple EH (SEH, n = 30); and (c) complex EH (CEH, n = 6). The results showed that immune cell subpopulations were significantly different between these three groups. Compared with the PP group, the proportion of CD45+ cells and neutrophils and the subtypes of T cells and macrophages were significantly increased in the SEH patients. Compared with the PP and SEH groups, subsets of immunocytes in the CEH group were significantly decreased, including the population of CD45+ cells and the subtypes of T cells and natural killer cells; in contrast, the proportion of macrophages was significantly increased. There were no significant differences between the other cell subsets in each group.
Conclusion: The changes in immune cell subsets may be closely associated with the progression of EH. Although the specific role of different immune cell subsets in the development of the diseases requires further study, the changes in the proportions of immune cell subsets should not be ignored.
Keywords: NK cell; T cell; abnormal uterine bleeding; endometrial hyperplasia; macrophage.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.Hum Pathol. 2010 Jan;41(1):26-32. doi: 10.1016/j.humpath.2009.06.012. Epub 2009 Sep 4. Hum Pathol. 2010. PMID: 19733383
-
Parameters of cellular immunity in perimenopausal patients with glandular and adenomatous endometrial hyperplasia.Bull Exp Biol Med. 2003 Jan;135(1):77-80. doi: 10.1023/a:1023410332246. Bull Exp Biol Med. 2003. PMID: 12717520
-
Enhanced expression of vascular endothelial growth factor and increased microvascular density in women with endometrial hyperplasia: a possible relationship with uterine natural killer cells.Rom J Morphol Embryol. 2015;56(2 Suppl):725-34. Rom J Morphol Embryol. 2015. PMID: 26429165
-
T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.Clin Rev Allergy Immunol. 2015 Dec;49(3):347-69. doi: 10.1007/s12016-015-8505-8. Clin Rev Allergy Immunol. 2015. PMID: 26445774 Review.
-
Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding.Radiol Clin North Am. 2003 Jul;41(4):769-80. doi: 10.1016/s0033-8389(03)00060-5. Radiol Clin North Am. 2003. PMID: 12899491 Review.
Cited by
-
"Iron triangle" of regulating the uterine microecology: Endometrial microbiota, immunity and endometrium.Front Immunol. 2022 Aug 9;13:928475. doi: 10.3389/fimmu.2022.928475. eCollection 2022. Front Immunol. 2022. PMID: 36016947 Free PMC article. Review.
-
Excess Heme Promotes the Migration and Infiltration of Macrophages in Endometrial Hyperplasia Complicated with Abnormal Uterine Bleeding.Biomolecules. 2022 Jun 19;12(6):849. doi: 10.3390/biom12060849. Biomolecules. 2022. PMID: 35740976 Free PMC article.
-
SHP2-Triggered Endothelial Cell Activation Fuels Estradiol-Independent Endometrial Sterile Inflammation.Adv Sci (Weinh). 2024 Nov;11(41):e2403038. doi: 10.1002/advs.202403038. Epub 2024 Sep 5. Adv Sci (Weinh). 2024. PMID: 39234819 Free PMC article.
-
Identification of potential biomarkers and immune infiltration characteristics in recurrent implantation failure using bioinformatics analysis.Front Immunol. 2023 Jan 26;14:992765. doi: 10.3389/fimmu.2023.992765. eCollection 2023. Front Immunol. 2023. PMID: 36776897 Free PMC article.
-
A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women.Sci Rep. 2025 Jan 6;15(1):1019. doi: 10.1038/s41598-024-83568-0. Sci Rep. 2025. PMID: 39762365 Free PMC article.
References
REFERENCES
-
- Ozdegirmenci O, Kayikcioglu F, Bozkurt U, Akgul MA, Haberal A. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia. Gynecol Obstet Invest. 2011;72:10-14.
-
- Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017;23:232-254.
-
- Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016;27:e8.
-
- Ali FF, Abdelzaher WY, Ibrahim RA, Elroby Ali DM. Amelioration of estrogen-induced endometrial hyperplasia in female rats by hemin via heme-oxygenase-1 expression, suppression of iNOS, p38 MAPK, and Ki67. Can J Physiol Pharmacol. 2019;97:1159-1168.
-
- Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, Ochiel DO. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol. 2010;63:544-565.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous